| Activity of antioxidant enzymes in seminal plasma and their relationship with lipid peroxidation of spermatozoa H Tavilani, MT Goodarzi, A Vaisi-Raygani, S Salimi, T Hassanzadeh International braz j urol 34, 485-491, 2008 | 126 | 2008 |
| Association between enzymatic and non-enzymatic antioxidant defense mechanism with apolipoprotein E genotypes in Alzheimer disease H Kharrazi, A Vaisi-Raygani, Z Rahimi, H Tavilani, M Aminian, ... Clinical Biochemistry 41 (12), 932-936, 2008 | 96 | 2008 |
| Antioxidant status in patients with psoriasis N Houshang, K Reza, S Masoud, E Ali, R Mansour, A Vaisi‐Raygani Cell Biochemistry and Function 32 (3), 268-273, 2014 | 91 | 2014 |
| Antioxidant status in patients with psoriasis N Houshang, K Reza, S Masoud, E Ali, R Mansour, A Vaisi‐Raygani Cell Biochemistry and Function 32 (3), 268-273, 2014 | 91 | 2014 |
| Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran AV Raygani, M Zahrai, AV Raygani, M Doosti, E Javadi, M Rezaei, ... Neuroscience letters 375 (1), 1-6, 2005 | 91 | 2005 |
| Association between apolipoprotein E polymorphism and serum lipid and apolipoprotein levels with Alzheimer's disease AV Raygani, Z Rahimi, H Kharazi, H Tavilani, T Pourmotabbed Neuroscience letters 408 (1), 68-72, 2006 | 75 | 2006 |
| Relationship between seminal antioxidant enzymes and the phospholipid and fatty acid composition of spermatozoa H Tavilani, MT Goodarzi, M Doosti, A Vaisi-Raygani, T Hassanzadeh, ... Reproductive BioMedicine Online 16 (5), 649-656, 2008 | 67 | 2008 |
| Paraoxonase 1 (PON1) 55 polymorphism, lipid profiles and psoriasis M Asefi, A Vaisi‐Raygani, F Bahrehmand, A Kiani, Z Rahimi, H Nomani, ... British Journal of Dermatology 167 (6), 1279-1286, 2012 | 66 | 2012 |
| The presence of apolipoprotein ε4 and ε2 alleles augments the risk of coronary artery disease in type 2 diabetic patients A Vaisi-Raygani, Z Rahimi, H Nomani, H Tavilani, T Pourmotabbed Clinical biochemistry 40 (15), 1150-1156, 2007 | 66 | 2007 |
| AT2R− 1332 G: A polymorphism and its interaction with AT1R 1166 A: C, ACE I/D and MMP-9− 1562 C: T polymorphisms: Risk factors for susceptibility to preeclampsia Z Rahimi, Z Rahimi, A Aghaei, A Vaisi-Raygani Gene 538 (1), 176-181, 2014 | 65 | 2014 |
| The angiotensin converting enzyme D allele is an independent risk factor for early onset coronary artery disease A Vaisi-Raygani, H Ghaneialvar, Z Rahimi, H Nomani, M Saidi, ... Clinical biochemistry 43 (15), 1189-1194, 2010 | 64 | 2010 |
| The frequency of factor V Leiden mutation, ACE gene polymorphism, serum ACE activity and response to ACE inhibitor and angiotensin II receptor antagonist drugs in Iranians type … Z Rahimi, V Felehgari, M Rahimi, H Mozafari, K Yari, A Vaisi-Raygani, ... Molecular biology reports 38, 2117-2123, 2011 | 61 | 2011 |
| ACE gene polymorphism and serum ACE activity in Iranians type II diabetic patients with macroalbuminuria V Felehgari, Z Rahimi, H Mozafari, A Vaisi-Raygani Molecular and cellular biochemistry 346, 23-30, 2011 | 60 | 2011 |
| Angiotensin converting enzyme insertion/deletion (I/D)(rs4646994) and Vegf polymorphism (+ 405G/C; rs2010963) in type II diabetic patients: Association with the risk of … A Moradzadegan, A Vaisi-Raygani, A Nikzamir, Z Rahimi Journal of the Renin-Angiotensin-Aldosterone System 16 (3), 672-680, 2015 | 59 | 2015 |
| Evaluation of total antioxidant capacity of saliva in high school students M Rahmani, V Ghoorchi, F Rezaei, AV Raygani Global Journal of Health Science 8 (4), 89, 2016 | 58 | 2016 |
| Synergistic effects of the MTHFR C677T and A1298C polymorphisms on the increased risk of micro-and macro-albuminuria and progression of diabetic nephropathy among Iranians with … M Rahimi, A Hasanvand, Z Rahimi, A Vaisi-Raygani, H Mozafari, ... Clinical biochemistry 43 (16-17), 1333-1339, 2010 | 58 | 2010 |
| Analysis of association between butyrylcholinesterase K variant and apolipoprotein E genotypes in Alzheimer's disease AV Raygani, M Zahrai, A Soltanzadeh, M Doosti, E Javadi, ... Neuroscience letters 371 (2-3), 142-146, 2004 | 55 | 2004 |
| Matrix metalloproteinase-2 functional promoter polymorphism G1575A is associated with elevated circulatory MMP-2 levels and increased risk of cardiovascular disease in systemic … F Bahrehmand, A Vaisi-Raygani, A Kiani, Z Rahimi, H Tavilani, SJ Navabi, ... Lupus 21 (6), 616-624, 2012 | 51 | 2012 |
| Prevalence of factor V Leiden (G1691A) and prothrombin (G20210A) among Kurdish population from Western Iran Z Rahimi, A Vaisi-Raygani, H Mozafari, H Kharrazi, M Rezaei, RL Nagel Journal of thrombosis and thrombolysis 25, 280-283, 2008 | 51 | 2008 |
| Matrix metalloproteinase 9 polymorphisms and systemic lupus erythematosus: correlation with systemic inflammatory markers and oxidative stress F Bahrehmand, A Vaisi-Raygani, A Kiani, Z Rahimi, H Tavilani, M Ardalan, ... Lupus 24 (6), 597-605, 2015 | 50 | 2015 |
